GLP-1s and Sexual Health: Libido, Testosterone, and What the Research Shows

If you search "Ozempic sex drive" online, you'll find a confusing mix. Some people say their libido skyrocketed after losing weight. Others say it disappeared entirely. The truth is somewhere in between — and it depends on which indirect pathways are dominant for you.

GLP-1 medications like Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), and Zepbound (tirzepatide) were never studied for sexual health effects in their clinical trials. There are no randomized controlled trials examining GLP-1 receptor agonists and libido. What we have is biological plausibility, related research from weight loss and bariatric surgery, and a growing number of patient reports.

Here's what the evidence actually supports.

Weight Loss and Testosterone in Men

This is the best-understood connection. Body fat and testosterone have an inverse relationship in men. Excess adipose tissue — particularly visceral fat around the abdomen — converts testosterone to estrogen through an enzyme called aromatase. The more visceral fat you carry, the more testosterone gets converted, and the lower your circulating free testosterone drops.

Weight loss reverses this. When men lose significant body fat, aromatase activity decreases, and testosterone levels recover.

A 2023 meta-analysis published in Obesity Reviews analyzed 35 studies on weight loss interventions and testosterone. The findings were consistent: men who lost 10% or more of their body weight saw average testosterone increases of 10-20%, with the biggest improvements in men who started with obesity and low testosterone.

GLP-1 users regularly lose 15-20% of body weight over 68 weeks. For men with obesity-related low testosterone, this weight loss can meaningfully improve testosterone levels — and with it, libido, erectile function, energy, and mood.

There is nothing GLP-1-specific about this mechanism. It happens with any weight loss that reduces visceral fat. The reason it matters for GLP-1 users is simply that these medications produce more weight loss, more consistently, than most other approaches.

For more on how GLP-1s affect men specifically, see our guide to GLP-1 for men.

Erectile Function: Why Weight Loss Helps

GLP-1 medications do not cause erectile dysfunction. In fact, the weight loss they produce tends to improve erectile function through several pathways:

Better blood flow. Excess weight and poor blood sugar control damage blood vessels and impair circulation — including to the penis. Weight loss improves endothelial function and nitric oxide availability, both of which are essential for erections.
Higher testosterone. As covered above, weight loss in obese men can raise testosterone, which supports erectile function and libido.
Cardiovascular improvement. GLP-1s have demonstrated 14-26% reduction in major cardiovascular events in trials like SELECT and SURPASS. Better heart health directly supports sexual function.
Sleep apnea improvement. Weight loss often reduces or eliminates obstructive sleep apnea, which is independently linked to ED. Better sleep also means more energy for sexual activity.

A 2024 study in The Journal of Sexual Medicine followed 312 men with obesity and ED who underwent significant weight loss (average 18% of body weight). After 12 months, 31% of men no longer met the clinical threshold for ED, and 45% reported meaningful improvement in erectile function scores.

No study has specifically measured ED outcomes in GLP-1 users, but the weight loss amounts are comparable. The mechanism is the same.

Why Some People Experience Lower Libido on GLP-1s

If weight loss is so good for sexual health, why do some users report the opposite? Several indirect factors can suppress libido during GLP-1 treatment:

Nausea and GI Discomfort

Nausea is the most common GLP-1 side effect, affecting 20-30% of users, especially during dose escalation. Feeling queasy is not compatible with feeling interested in sex. For most people, nausea peaks in the first 4-8 weeks and improves as the body adjusts. See our GLP-1 side effects guide for management strategies.

Fatigue and Low Energy

GLP-1 users often eat significantly fewer calories than before. If calorie intake drops too far, especially without enough protein, energy plummets. Fatigue is one of the most commonly reported GLP-1 complaints and a direct libido killer. Our guide to fatigue and energy on GLP-1s covers how to eat and supplement to keep your energy up.

Calorie Restriction and Hormonal Adaptation

Severe calorie restriction triggers a stress response. Cortisol rises. The body downregulates non-essential functions — and from a biological standpoint, reproduction is non-essential when the body perceives scarcity. This is the same mechanism behind hypothalamic amenorrhea in women who undereat. In men, chronic undereating can suppress the hypothalamic-pituitary-gonadal axis, lowering testosterone and libido.

The fix is not to stop your GLP-1. It is to eat enough — particularly enough protein and healthy fats — to keep your body out of perceived starvation mode.

Psychological Factors

Major body changes affect how people feel about themselves and their relationships. Some people feel more confident and desirable after weight loss. Others experience anxiety about loose skin, body image, or changes in how their partner relates to them. Some feel a loss of identity if food or eating played a central social role. See our article on GLP-1 and mental health for more on the psychological side of treatment.

Medication Interactions

GLP-1s themselves do not suppress libido. But other medications commonly prescribed alongside GLP-1s might. Antidepressants (SSRIs in particular), blood pressure medications, and some pain medications can all affect sexual function. If libido changes coincide with starting or adjusting a non-GLP-1 medication, that medication may be the cause.

Women: PCOS, Hormones, and Libido

The GLP-1 and sexual health conversation is not just about men. Women with PCOS may see indirect sexual health benefits from GLP-1 treatment.

PCOS is characterized by insulin resistance, hyperandrogenism (elevated male hormones including testosterone), and often obesity. The hormonal imbalance drives symptoms like irregular periods, acne, hirsutism, and reduced fertility — all of which can affect how a woman feels about her body and her sex drive.

GLP-1 medications may help by:

Improving insulin sensitivity. Lower insulin levels reduce ovarian androgen production, which can normalize hormone ratios.
Supporting weight loss. Even modest weight loss (5-10%) can restore menstrual regularity in PCOS.
Reducing hyperandrogenism symptoms. As androgen levels normalize, symptoms like unwanted hair growth and acne may improve, which can boost body image and confidence.

A 2024 randomized trial published in The Lancet Diabetes & Endocrinology found that semaglutide plus lifestyle intervention produced significantly greater improvements in PCOS metabolic markers than lifestyle alone, including reductions in free androgen index and improvements in menstrual regularity.

Better hormonal balance, more regular cycles, and improved body image can all contribute to a healthier libido. But this is an indirect benefit — not a direct effect of the GLP-1 on sexual function. See our detailed guide on PCOS and GLP-1 for the full picture.

The Estrogen Factor: Weight Loss and Hormonal Shifts in Women

Just as weight loss can raise testosterone in men, it can affect estrogen in women. Adipose tissue produces estrone, a form of estrogen. When body fat drops quickly, estrogen production from fat tissue also drops.

For some women — particularly those who are perimenopausal or postmenopausal — this estrogen decline can cause vaginal dryness, discomfort during sex, and reduced libido. These are real effects, but they are consequences of rapid weight loss, not of the GLP-1 medication itself.

For more on how these hormonal shifts interact with menopause, see our article on GLP-1 and menopause. For vaginal health specifically, see GLP-1 and vaginal health.

Timeline: When to Expect Changes

Based on patient reports and what is known about the biology of weight loss and hormones, here is a rough timeline:

Weeks 1-4: Nausea, fatigue, and calorie reduction are at their peak. Libido may feel suppressed. This is the adjustment period and is usually temporary.
Months 2-4: Weight loss accelerates. For men, testosterone may begin rising. For women with PCOS, hormonal improvements may start. Energy may improve if eating enough protein. Libido changes are mixed during this phase — some feel better, some still feel off.
Months 5-8: Most people have adjusted to their maintenance dose. GI side effects are typically mild or resolved. Weight loss continues at a slower pace. If libido was suppressed by early side effects, it often recovers here. Positive effects — better energy, improved body image, higher testosterone for men — become more noticeable.
Month 9 and beyond: Hormone levels stabilize at the new body weight. Sexual health at this point usually reflects the new baseline — generally improved for people who had obesity-related issues, though some women may notice persistent vaginal dryness related to lower estrogen.

These timelines are based on aggregated clinical data and patient reports, not studies specifically designed to track sexual health on GLP-1s.

What Is Proven vs. What Is Reported

This distinction matters because the wrong assumption leads to the wrong intervention.

Supported by research:

Weight loss from any method improves testosterone in obese men
Weight loss improves erectile function in men with obesity-related ED
GLP-1s produce significant, sustained weight loss
PCOS symptoms improve with weight loss and improved insulin sensitivity
Severe calorie restriction can suppress reproductive hormones
Nausea, fatigue, and stress reduce libido

Reported by patients but not proven in GLP-1-specific studies:

GLP-1s directly increase or decrease libido
GLP-1s directly affect testosterone levels
GLP-1s cause sexual dysfunction as a drug-specific side effect

The practical takeaway: if your libido improved on a GLP-1, the mechanism is almost certainly the weight loss and its downstream hormonal benefits. If your libido decreased, the most likely culprits are nausea, fatigue, undereating, or psychological adjustment — all of which are addressable without stopping your medication.

Practical Steps

If you are experiencing unwanted libido changes on a GLP-1:

Check your eating. Are you getting enough calories, protein, and healthy fats? Undereating suppresses hormones. Aim for at least 0.7g of protein per pound of goal body weight, and do not drop below 1,200 calories daily without medical supervision.
Address nausea and fatigue. These are the top libido-killers in the early months. Eat small, bland meals. Stay hydrated. Talk to your doctor about anti-nausea options if needed. Our fatigue and energy guide has more detail.
Give it time. Most early side effects improve within 8-12 weeks. If you are in the dose-escalation phase, libido may recover on its own once you stabilize.
Check other medications. SSRIs, blood pressure drugs, and other common prescriptions can affect sexual function. If your libido changed after starting or adjusting a different medication, that may be the cause.
Talk to your doctor. If low libido persists beyond the adjustment period, ask about checking your hormone levels (testosterone for men, estradiol and SHBG for women). Persistent vaginal dryness in women may respond to OTC moisturizers or low-dose vaginal estrogen.

Questions for Your Doctor

Could my libido changes be related to weight loss and hormone shifts rather than the GLP-1 medication itself?
Should we check my testosterone or estrogen levels if sexual health changes persist?
Are any of my other medications known to affect libido or sexual function?
Would adjusting my GLP-1 dose help with the nausea and fatigue that are affecting my sex drive?
Is low-dose vaginal estrogen appropriate for me if I am experiencing dryness?

When to Get Help

See your doctor if you experience:

Persistent low libido that does not improve after the first 2-3 months
New or worsening erectile dysfunction
Vaginal dryness or pain with sex that does not respond to OTC products
Signs of hormonal imbalance (hot flashes, irregular periods, breast tenderness in women; persistent fatigue, muscle loss, or mood changes in men)
Any sexual health change that causes you distress

Do not stop your GLP-1 medication without talking to your prescribing provider.

The Bottom Line

GLP-1 medications do not directly affect sexual health. But the weight loss they produce can have significant indirect effects — mostly positive, sometimes negative during adjustment. Men with obesity-related low testosterone often see improvement. Women with PCOS may experience hormonal benefits. Both sexes can feel better about their bodies.

On the flip side, nausea, fatigue, calorie restriction, and psychological adjustment can temporarily suppress libido. These are usually short-term problems with practical solutions.

The key is recognizing which pathway is driving your experience — and addressing the real cause rather than blaming the medication.

This article is for informational purposes only and does not constitute medical advice. Talk to your healthcare provider about any sexual health concerns or before making changes to your medication.